Sn 38 | List of Frontiers open access articles

Brief Research Report

Published on 29 Apr 2021

7-Ethyl-10-Hydroxycamptothecin, a DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth

in Experimental Pharmacology and Drug Discovery

Airong Wang
Lingling Li
Mengya Li
Shujuan Wang
Chong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.664176

3,529 views
5 citations

Original Research

Published on 21 Aug 2025

Model-based prediction of nanoparticle and dissolved form ratios using total concentration data: a case study of SNB-101

in Pharmacology of Anti-Cancer Drugs

Jinha Park
Soo Hyeon Bae
Sangil Jeon
Young Hwan Park
Dong Cheol Lee
Seunghoon Han

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1556618

1,428 views

Original Research

Published on 27 Oct 2017

Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity

in Drug Metabolism and Transport

Huan-yu Guan
Peng-fei Li
Xiao-ming Wang
Jia-jing Yue
Yang He
Xiao-mei Luo
Mei-feng Su
Shang-gao Liao
Yue Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2017.00769

5,354 views
28 citations

Original Research

Published on 15 Feb 2022

Click Chemistry and Multicomponent Reaction for Linker Diversification of Zinc Dipicolylamine-Based Drug Conjugates

in Medicinal and Pharmaceutical Chemistry

Ching-Hua Tsai
Tai-Yu Chiu
Chiung-Tong Chen
Chia-Yu Hsu
Ya-Ru Tsai
Teng-Kuang Yeh
Kuan-Hsun Huang
Lun Kelvin Tsou

Frontiers in Chemistry

doi 10.3389/fchem.2021.822587

5,820 views
1 citation

Original Research

Published on 13 Jul 2023

The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells

in Experimental Pharmacology and Drug Discovery

Hai-Ling Gao
Qingbin Cui
Jing-Quan Wang
Charles R. Ashby
Yanchun Chen
Zhi-Xin Shen
Zhe-Sheng Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1235285

6,105 views
23 citations

Original Research

Published on 24 Sep 2025

TG6002 oncolytic vaccinia virus and chemotherapy synergy: a promising strategy for pancreatic ductal adenocarcinoma

in Virology

Johann Foloppe
Isabelle Farine
Christelle Pichon
Juliette Kempf
Julie Hortelano
Baptiste Moreau
Sandrine Cochin
Armelle Takeda
Patrick Pessaux
Philippe Erbs

Frontiers in Microbiology

doi 10.3389/fmicb.2025.1656984

2,572 views

Original Research

Published on 13 Feb 2025

Calcium-dependent adhesion protein CDH18, a potential biomarker for prognosis in uterine corpus endometrial carcinoma

in Molecular Diagnostics and Therapeutics

Xiaoxuan Tang
Shanxing Dang
Jie Qiu
Ruilan Zhou
Jing Ling
Limei Zhang
Xiaopeng Peng
Qingyun Li
Jin Liu
Wei Liao

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2025.1530253

3,528 views
1 citation

Original Research

Accepted on 25 Feb 2026

Integrative Single-Cell Analysis Reveals Immunogenic Cell Death–Associated Heterogeneity and Identifies a Robust Prognostic Signature in Osteosarcoma with Experimental Validation

in Inflammation Pharmacology

Zhaochen Xu
Jiangbo Han
Meng Zhang
Fei Chen
Hongli Deng
Weiguo Bian

Frontiers in Pharmacology

Articles

7-Ethyl-10-Hydroxycamptothecin, a DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth

Model-based prediction of nanoparticle and dissolved form ratios using total concentration data: a case study of SNB-101

Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity

Click Chemistry and Multicomponent Reaction for Linker Diversification of Zinc Dipicolylamine-Based Drug Conjugates

The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells

TG6002 oncolytic vaccinia virus and chemotherapy synergy: a promising strategy for pancreatic ductal adenocarcinoma

Calcium-dependent adhesion protein CDH18, a potential biomarker for prognosis in uterine corpus endometrial carcinoma

Integrative Single-Cell Analysis Reveals Immunogenic Cell Death–Associated Heterogeneity and Identifies a Robust Prognostic Signature in Osteosarcoma with Experimental Validation